These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27863679)

  • 1. Effect of moisture sorption on the performance of crospovidone.
    Hiew TN; Johan NAB; Desai PM; Chua SM; Loh ZH; Heng PWS
    Int J Pharm; 2016 Nov; 514(1):322-331. PubMed ID: 27863679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast disintegrating tablets containing Rhodiola rosea L. extract.
    Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
    Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on moisture isotherms of formulations: the use of polynomial equations to predict the moisture isotherms of tablet products.
    Li Y; Sanzgiri YD; Chen Y
    AAPS PharmSciTech; 2003 Dec; 4(4):E59. PubMed ID: 15198554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionality of wet-granulated disintegrant in comparison to directly incorporated disintegrant in a poorly water-soluble tablet matrix.
    Veronica N; Lee ESM; Heng PWS; Liew CV
    Int J Pharm; 2024 Aug; 661():124467. PubMed ID: 39004293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of humidity on the disintegrant property of alpha-cellulose.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2005; 62(1):39-44. PubMed ID: 16022492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Hygroscopic Formulation Ingredients on the Sorption Characteristics of Tablets.
    Fischer M; Schepky G
    Drug Dev Ind Pharm; 1995; 21(3):279-300. PubMed ID: 36600548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incompatibility of croscarmellose sodium with alkaline excipients in a tablet formulation.
    Bindra DS; Stein D; Pandey P; Barbour N
    Pharm Dev Technol; 2014 May; 19(3):285-9. PubMed ID: 23528069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro determination of aceclofenac Mouth Dissolving Tablets.
    Shobhit S; Gupta SK
    Polim Med; 2013; 43(4):227-9. PubMed ID: 24596037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crospovidone interactions with water. II. Dynamic vapor sorption analysis of the effect of Polyplasdone particle size on its uptake and distribution of water.
    Saripella KK; Mallipeddi R; Neau SH
    Int J Pharm; 2014 Nov; 475(1-2):174-80. PubMed ID: 25152165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets.
    Late SG; Yu YY; Banga AK
    Int J Pharm; 2009 Jan; 365(1-2):4-11. PubMed ID: 18778759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of crospovidone and hydroxypropyl cellulose on carbamazepine in high-dose tablet formulation.
    Flicker F; Betz G
    Drug Dev Ind Pharm; 2012 Jun; 38(6):697-705. PubMed ID: 22010838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets.
    Mahesparan VA; Bin Abd Razak FS; Ming LC; Uddin AH; Sarker MZI; Bin LK
    Int J Pharm Compd; 2020; 24(2):148-155. PubMed ID: 32196477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tablet disintegration studied by high-resolution real-time magnetic resonance imaging.
    Quodbach J; Moussavi A; Tammer R; Frahm J; Kleinebudde P
    J Pharm Sci; 2014 Jan; 103(1):249-55. PubMed ID: 24475490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moisture sorption, compressibility and caking of lactose polymorphs.
    Listiohadi Y; Hourigan JA; Sleigh RW; Steele RJ
    Int J Pharm; 2008 Jul; 359(1-2):123-34. PubMed ID: 18485633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights on the role of excipients and tablet matrix porosity on aspirin stability.
    Veronica N; Liew CV; Heng PWS
    Int J Pharm; 2020 Apr; 580():119218. PubMed ID: 32165224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of ethanol on superdisintegrants and on tablets disintegration.
    Bisharat L; AlKhatib HS; Muhaissen S; Quodbach J; Blaibleh A; Cespi M; Berardi A
    Eur J Pharm Sci; 2019 Mar; 129():140-147. PubMed ID: 30630089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.